GPBP1L1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	18 studies	30% ± 11%	Explore
macrophage	13 studies	29% ± 13%	Explore
microglial cell	11 studies	30% ± 12%	Explore
oligodendrocyte	11 studies	28% ± 10%	Explore
astrocyte	10 studies	34% ± 14%	Explore
epithelial cell	9 studies	38% ± 20%	Explore
fibroblast	9 studies	25% ± 8%	Explore
ciliated cell	8 studies	27% ± 10%	Explore
adipocyte	8 studies	25% ± 5%	Explore
type I pneumocyte	8 studies	25% ± 8%	Explore
oligodendrocyte precursor cell	8 studies	26% ± 13%	Explore
B cell	7 studies	22% ± 4%	Explore
pericyte	7 studies	25% ± 8%	Explore
basal cell	7 studies	30% ± 18%	Explore
smooth muscle cell	6 studies	22% ± 4%	Explore
myeloid cell	6 studies	27% ± 5%	Explore
club cell	6 studies	27% ± 10%	Explore
dendritic cell	6 studies	29% ± 10%	Explore
endothelial cell of lymphatic vessel	6 studies	29% ± 10%	Explore
type II pneumocyte	6 studies	24% ± 7%	Explore
natural killer cell	5 studies	19% ± 2%	Explore
non-classical monocyte	5 studies	29% ± 11%	Explore
CD4-positive, alpha-beta T cell	5 studies	19% ± 3%	Explore
glutamatergic neuron	5 studies	46% ± 23%	Explore
cardiac muscle cell	5 studies	27% ± 6%	Explore
regulatory T cell	5 studies	17% ± 3%	Explore
GABAergic neuron	5 studies	39% ± 19%	Explore
monocyte	5 studies	28% ± 7%	Explore
goblet cell	5 studies	36% ± 22%	Explore
T cell	5 studies	21% ± 3%	Explore
classical monocyte	4 studies	26% ± 9%	Explore
effector memory CD8-positive, alpha-beta T cell	4 studies	19% ± 2%	Explore
lymphocyte	4 studies	27% ± 6%	Explore
CD8-positive, alpha-beta T cell	4 studies	19% ± 3%	Explore
hepatocyte	4 studies	49% ± 11%	Explore
respiratory goblet cell	4 studies	30% ± 12%	Explore
interneuron	4 studies	38% ± 21%	Explore
neuron	4 studies	41% ± 18%	Explore
CD16-negative, CD56-bright natural killer cell, human	3 studies	18% ± 2%	Explore
CD16-positive, CD56-dim natural killer cell, human	3 studies	17% ± 2%	Explore
conventional dendritic cell	3 studies	29% ± 13%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	3 studies	17% ± 1%	Explore
squamous epithelial cell	3 studies	39% ± 20%	Explore
retinal cone cell	3 studies	28% ± 3%	Explore
mononuclear phagocyte	3 studies	24% ± 4%	Explore
vein endothelial cell	3 studies	34% ± 22%	Explore
endothelial cell of vascular tree	3 studies	30% ± 16%	Explore
abnormal cell	3 studies	29% ± 19%	Explore
connective tissue cell	3 studies	17% ± 1%	Explore
enteroendocrine cell	3 studies	22% ± 5%	Explore
leukocyte	3 studies	24% ± 6%	Explore
alveolar macrophage	3 studies	36% ± 11%	Explore
mast cell	3 studies	23% ± 5%	Explore
plasmacytoid dendritic cell	3 studies	21% ± 4%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
brain	10 studies	33% ± 18%	Explore
lung	9 studies	21% ± 6%	Explore
eye	4 studies	26% ± 16%	Explore
heart	4 studies	22% ± 3%	Explore
peripheral blood	3 studies	26% ± 3%	Explore
liver	3 studies	38% ± 11%	Explore
intestine	3 studies	20% ± 4%	Explore
adipose	3 studies	26% ± 2%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
breast	100%	6612.84	459 / 459	100%	69.77	1118 / 1118
esophagus	100%	7049.75	1445 / 1445	100%	54.07	183 / 183
intestine	100%	7803.79	966 / 966	100%	54.57	527 / 527
lung	100%	7227.10	578 / 578	100%	57.89	1155 / 1155
ovary	100%	6089.16	180 / 180	100%	48.96	430 / 430
prostate	100%	7051.46	245 / 245	100%	61.55	502 / 502
stomach	100%	5664.29	359 / 359	100%	49.60	286 / 286
bladder	100%	6088.52	21 / 21	100%	53.94	503 / 504
thymus	100%	7941.06	653 / 653	100%	69.63	603 / 605
uterus	100%	7644.34	170 / 170	100%	57.15	457 / 459
kidney	100%	5942.71	89 / 89	100%	43.91	897 / 901
brain	100%	3813.31	2634 / 2642	100%	30.74	704 / 705
pancreas	100%	4187.79	328 / 328	99%	50.41	176 / 178
liver	100%	5010.69	226 / 226	99%	35.31	401 / 406
skin	100%	7699.74	1809 / 1809	96%	39.40	455 / 472
adrenal gland	100%	5030.00	258 / 258	94%	21.30	217 / 230
adipose	100%	6103.39	1204 / 1204	0%	0	0 / 0
blood vessel	100%	5863.43	1335 / 1335	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	40.20	29 / 29
muscle	100%	4546.98	803 / 803	0%	0	0 / 0
spleen	100%	7475.41	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	57.15	45 / 45
ureter	0%	0	0 / 0	100%	23.03	1 / 1
heart	99%	4255.30	854 / 861	0%	0	0 / 0
peripheral blood	98%	5419.13	913 / 929	0%	0	0 / 0
eye	0%	0	0 / 0	80%	19.24	64 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0006351	Biological process	DNA-templated transcription
GO_0045893	Biological process	positive regulation of DNA-templated transcription
GO_0006355	Biological process	regulation of DNA-templated transcription
GO_0005634	Cellular component	nucleus
GO_0003677	Molecular function	DNA binding
GO_0005515	Molecular function	protein binding
GO_0003723	Molecular function	RNA binding

IV. Literature review

[source]

Gene name	GPBP1L1
Protein name	Vasculin-like protein 1 (GC-rich promoter-binding protein 1-like 1)
Synonyms	SP192
Description	FUNCTION: Possible transcription factor. .
Accessions	ENST00000290795.7 Q9HC44 ENST00000355105.8

GPBP1L1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review